These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 23629014

  • 1. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C, Pourcel C, Richardot C, Plésiat P, Fichant G, Cavallo JD, Mérens A, GERPA Study Group.
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [Abstract] [Full Text] [Related]

  • 2. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D, Richardot C, Müller E, Robert-Nicoud M, Llanes C, Plésiat P, Jeannot K.
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [Abstract] [Full Text] [Related]

  • 3. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ, Black JA, Lister PD, Hanson ND.
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [Abstract] [Full Text] [Related]

  • 4. ISPa46, a novel insertion sequence in the oprD porin gene of an imipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient in Marseille, France.
    Diene SM, L'homme T, Bellulo S, Stremler N, Dubus JC, Mely L, Leroy S, Degand N, Rolain JM.
    Int J Antimicrob Agents; 2013 Sep; 42(3):268-71. PubMed ID: 23880169
    [Abstract] [Full Text] [Related]

  • 5. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V, Arpin C, Dupart V, Scavelli A, Coulange L, André C, Fischer I, Grobost F, Brochet JP, Lagrange I, Dutilh B, Jullin J, Noury P, Larribet G, Quentin C.
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [Abstract] [Full Text] [Related]

  • 6. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z, Satana D, Kayacan C, Can B, Gönüllü N, Küçükbasmacı O.
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [Abstract] [Full Text] [Related]

  • 7. Phenotypic and genetic resistance traits of Pseudomonas aeruginosa strains infecting cystic fibrosis patients: A French cohort study.
    Courtois N, Caspar Y, Maurin M.
    Int J Antimicrob Agents; 2018 Sep; 52(3):358-364. PubMed ID: 29775685
    [Abstract] [Full Text] [Related]

  • 8. OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-β-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea.
    Lee JY, Ko KS.
    Int J Antimicrob Agents; 2012 Aug; 40(2):168-72. PubMed ID: 22633564
    [Abstract] [Full Text] [Related]

  • 9. Role of efflux pumps: MexAB-OprM and MexXY(-OprA), AmpC cephalosporinase and OprD porin in non-metallo-β-lactamase producing Pseudomonas aeruginosa isolated from cystic fibrosis and burn patients.
    Aghazadeh M, Hojabri Z, Mahdian R, Nahaei MR, Rahmati M, Hojabri T, Pirzadeh T, Pajand O.
    Infect Genet Evol; 2014 Jun; 24():187-92. PubMed ID: 24694825
    [Abstract] [Full Text] [Related]

  • 10. Carbapenem-resistant Pseudomonas aeruginosa strains from a Spanish hospital: characterization of metallo-beta-lactamases, porin OprD and integrons.
    Rojo-Bezares B, Estepa V, Cebollada R, de Toro M, Somalo S, Seral C, Castillo FJ, Torres C, Sáenz Y.
    Int J Med Microbiol; 2014 May; 304(3-4):405-14. PubMed ID: 24594145
    [Abstract] [Full Text] [Related]

  • 11. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
    Clark ST, Sinha U, Zhang Y, Wang PW, Donaldson SL, Coburn B, Waters VJ, Yau YCW, Tullis DE, Guttman DS, Hwang DM.
    Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
    [Abstract] [Full Text] [Related]

  • 12. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O.
    APMIS Suppl; 2003 May; (116):1-47. PubMed ID: 14692154
    [Abstract] [Full Text] [Related]

  • 13. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH, Kwon GC, Kim S, Koo SH.
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M, Deshpande LM, Costello A, Davies TA, Jones RN.
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of Pseudomonas aeruginosa to antimicrobials: a 2004 French multicentre hospital study.
    Cavallo JD, Hocquet D, Plesiat P, Fabre R, Roussel-Delvallez M, GERPA (Groupe d'Etude de la Résistance de Pseudomonas aeruginosa aux antibiotiques).
    J Antimicrob Chemother; 2007 May; 59(5):1021-4. PubMed ID: 17412726
    [Abstract] [Full Text] [Related]

  • 16. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Chinese hospitals.
    Wang J, Zhou JY, Qu TT, Shen P, Wei ZQ, Yu YS, Li LJ.
    Int J Antimicrob Agents; 2010 May; 35(5):486-91. PubMed ID: 20185276
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic susceptibility and mechanisms of beta-lactam resistance among clinical strains of Pseudomonas aeruginosa: first report in Algeria.
    Drissi M, Ahmed ZB, Dehecq B, Bakour R, Plésiat P, Hocquet D.
    Med Mal Infect; 2008 Apr; 38(4):187-91. PubMed ID: 18395380
    [Abstract] [Full Text] [Related]

  • 18. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H, Sáenz Y, Nichols WW, Tulkens PM, Van Bambeke F.
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [Abstract] [Full Text] [Related]

  • 19. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N, Giske CG, Jalal S, Keijser B, Kronvall G, Wretlind B.
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [Abstract] [Full Text] [Related]

  • 20. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD, Leblanc F, Fabre R.
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.